Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
UBS analyst Joshua Spector maintains Cabot (NYSE:CBT) with a Neutral and lowers the price target from $82 to $65.
OutlookCommenting on the outlook for the Company, Keohane said, "Looking ahead to fiscal 2026, we do not yet see signs of i...
Cabot (NYSE:CBT) reported quarterly earnings of $1.70 per share which beat the analyst consensus estimate of $1.68 by 1.01 perc...
Mizuho analyst John Roberts maintains Cabot (NYSE:CBT) with a Outperform and lowers the price target from $90 to $88.
UBS analyst Joshua Spector maintains Cabot (NYSE:CBT) with a Neutral and raises the price target from $81 to $82.
Cabot (NYSE:CBT) affirms FY2025 Adj EPS guidance from $7.15-$7.50 to $7.15-$7.50 vs $7.30 analyst estimate..
Cabot (NYSE:CBT) reported quarterly earnings of $1.90 per share which beat the analyst consensus estimate of $1.81 by 4.97 perc...
